Form 4 for PHR Phreesia, Inc.
Accepted 2024-06-21 00:00:00 ET · period of report 2024-06-18 · accession 0001127602-24-019127 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-06-21 | 2024-06-18+ | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $19.53 | -107 | 7,046 | -1% | -$2,089 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-20 | S | D | 66 | $19.73 | 6,980 | I By Spouse | — | — | |
| 2 | Common | Common Stock | 2024-06-18 | S | D | 41 | $19.20 | 7,046 | I By Spouse | — | — |